BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 1379258)

  • 1. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults.
    Young SC; Underwood LE; Celniker A; Clemmons DR
    J Clin Endocrinol Metab; 1992 Aug; 75(2):603-8. PubMed ID: 1379258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats.
    Gargosky SE; Tapanainen P; Rosenfeld RG
    Endocrinology; 1994 May; 134(5):2267-76. PubMed ID: 7512499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans.
    Lieberman SA; Bukar J; Chen SA; Celniker AC; Compton PG; Cook J; Albu J; Perlman AJ; Hoffman AR
    J Clin Endocrinol Metab; 1992 Jul; 75(1):30-6. PubMed ID: 1377706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent responses of serum insulin-like growth factor-I and liver growth hormone (GH) receptors to exogenous GH in protein-restricted rats.
    Thissen JP; Triest S; Underwood LE; Maes M; Ketelslegers JM
    Endocrinology; 1990 Feb; 126(2):908-13. PubMed ID: 2298175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults.
    Smith WJ; Underwood LE; Clemmons DR
    J Clin Endocrinol Metab; 1995 Feb; 80(2):443-9. PubMed ID: 7531712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated.
    Näntö-Salonen K; Muller HL; Hoffman AR; Vu TH; Rosenfeld RG
    Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis.
    Møller S; Juul A; Becker U; Flyvbjerg A; Skakkebaek NE; Henriksen JH
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1148-57. PubMed ID: 7536200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans.
    Clemmons DR; Smith-Banks A; Underwood LE
    J Clin Endocrinol Metab; 1992 Jul; 75(1):234-8. PubMed ID: 1619015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat.
    Glasscock GF; Hein AN; Miller JA; Hintz RL; Rosenfeld RG
    Endocrinology; 1992 Jan; 130(1):203-10. PubMed ID: 1370151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
    Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
    Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Guevara-Aguirre J; Diamond FB; Baxter RC; Rosenbloom AL; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1683-9. PubMed ID: 7505289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P; Brismar K; Rosenfeld RG; Hall K
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus.
    Bach MA; Chin E; Bondy CA
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1040-5. PubMed ID: 7525624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia.
    Zapf J; Schmid C; Guler HP; Waldvogel M; Hauri C; Futo E; Hossenlopp P; Binoux M; Froesch ER
    J Clin Invest; 1990 Sep; 86(3):952-61. PubMed ID: 1697608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of insulin-like growth factor (IGF) and IGF-binding protein responses to a single dose of growth hormone.
    Lee PD; Durham SK; Martinez V; Vasconez O; Powell DR; Guevara-Aguirre J
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2266-74. PubMed ID: 9215305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of dietary protein supplementation on insulin-like growth factors (IGFs) and IGF-binding proteins in children with shigellosis.
    Pucilowska JB; Davenport ML; Kabir I; Clemmons DR; Thissen JP; Butler T; Underwood LE
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1516-21. PubMed ID: 7505287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.
    Vaccarello MA; Diamond FB; Guevara-Aguirre J; Rosenbloom AL; Fielder PJ; Gargosky S; Cohen P; Wilson K; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Jul; 77(1):273-80. PubMed ID: 7686916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of insulin-like growth factor-binding proteins in serum and lymph of lactating cows by somatotropin.
    Cohick WS; McGuire MA; Clemmons DR; Bauman DE
    Endocrinology; 1992 Mar; 130(3):1508-14. PubMed ID: 1371453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of insulin-like growth factor (IGF) binding proteins in transgenic mice with altered expression of growth hormone and IGF-I.
    Camacho-Hubner C; Clemmons DR; D'Ercole AJ
    Endocrinology; 1991 Sep; 129(3):1201-6. PubMed ID: 1714829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.